Catalyst

ABBV earnings

Jul 30, 2026

ABBV earnings — 2026-07-30

Reported the quarter ending 2026-06-30: revenue $16.99B, diluted EPS $2.03, net income $3.61B (SEC filing, revenue corroborated by the desk's provider cache). Across the print the stock moved -4.7% (close before → first close after).

Backfilled from filed financials — a record of the print, not an analyst read.

6 events

DateTypeEvent

Jul 30 Market BriefThe Block Clears: Citadel Buys the Book, Memory Rips Jul 29 Market BriefThe Split Print: Compute Sellers Collect, Compute Buyers Pay Jul 31 Market BriefOne Margin Call, One Record Day Jul 31 ScanBiotech Scan Jul 31 CatalystABBV earnings Jul 28 ScanBiotech Scan

No direct external sources are attached to this read.